Intrahepatic Cholestasis Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
MIRM | C | Mirum Pharmaceuticals, Inc. | 2.04 | |
ABT | C | Abbott Laboratories | -1.12 |
Related Industries: Biotechnology Medical Devices
Related ETFs - A few ETFs which own one or more of the above listed Intrahepatic Cholestasis stocks.
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
IHI | B | iShares U.S. Medical Devices ETF | 16.64 | |
PJP | A | PowerShares Dynamic Pharmaceuticals | 5.95 | |
PCGG | D | Polen Capital Global Growth ETF | 4.58 | |
HART | A | IQ Healthy Hearts ETF | 4.26 | |
VIRS | A | Pacer BioThreat Strategy ETF | 4.08 |
Compare ETFs
Related Industries:
Biotechnology
Medical Devices
- Intrahepatic Cholestasis
Intrahepatic cholestasis is a condition in which the flow of bile from the liver is blocked or reduced. This can lead to a buildup of bile acids in the liver and other organs, causing symptoms such as itching, jaundice, and dark urine. It can be caused by a variety of conditions, including liver disease, certain medications, and pregnancy. Treatment depends on the underlying cause.
Popular Now
Recent Comments
- TraderMike on New Scans: Strong, Oversold Stocks and Weak, Overbought Stocks
- ZealousTrout235 on New Scans: Strong, Oversold Stocks and Weak, Overbought Stocks
- TraderMike on Market Recap for Tuesday, May 21, 2024
- CharmingMole371 on Market Recap for Tuesday, May 21, 2024
- TraderMike on IZM
From the Blog
Featured Articles